BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
The aim of the study is important and there are many good aspects throughout the paper. However, because a review is meant to help improve potentially critical aspects of the paper, the following is focusing on that.
Aspects that need attendance and potentially revision: 1) Throughout the paper, authors use the words "prevention" and "early diagnosis= early detection" interchangeable. Prevention is not early detection, however. For instance, in the introduction authors discuss PSA screening, what is early detection of a cancer that already exists. Screening does not prevent cancer. Because studies document that a certain number of lay people holds the misconception that screening would prevent cancer, I suggest that within the current study here, authors should be vey clear about what they are after. It seems it is "early detection" but the title and certain parts of the paper talk about "prevention."
2) The aim of the study is to determine and evaluate evidence of men who had not been diagnosed with prostate cancer. However, of the 7 populations reviewed 3 populations include men with a prostate cancer diagnosis and in some others there are men with elevated risk (including family history of PC). Whereas in the first setting (there is already a diagnosis) we do not talk about "early diagnosis/early detection" anymore (thus, opposing the aim of the study), the latter-as a high risk population-may also differ in certain ways from low-risk, undiagnosed men. There are different ways of how to treat this aspect: First, the aim of the study needs to be extended to make it clear that all results apply to all men (regardless of state of diagnosis). This would be the easiest but also mingles together findings, which I think might be better separated. Here is why: PSA testing in men with an PC diagnosis (is called testing not early detection anymore in diagnosed men) make a lot of sense because the relative change in the PSA value over time helps predict the potential recurrence of PC. PSA screening/early detection of PC may make sense in men with elevated risk (less controversy than it is on early detection in average-risk men). Further, in both of these groups the threat of prostate cancer is quite real, what should influence preferences and attitudes. This is a very different situation in men without a diagnosis or the knowledge of an elevated risk. Also, and as the authors point out rightly, for average risk men PSA screening/early detection is surrounded by a lot of controversy due to very modest disease-specific mortality benefits (about 1 in 1,000; only shown in the ERSPC trial, in the PLCO no reduction), no overall mortality benefit, and the harms of overdiagnosis/overtreatment (in about 35 in 1,000). Based on this evidence from RCT, early detection of PC had a D recommendation by the US Preventive Task Force, which was changed to a C recommendation after a lot of social/political pressure (not scientific). Due to the fact that testing/early detection might be in some men more appropriate than in others, pulling results together seems a bit awkward to me. The most stringent analysis would therefore be to only report results on average risk men.
3) This suggestion may lead to the argument that there are already so few studies that taking of these with men at elevated risk or with diagnosed men would only leave few. Yet, when going through the literature search algorithm for this study I wondered why there is no inclusion of words such as "PSA" or "early detection" paired with attitudes, preferences, and also with decision making. I suggest running new literature search using these additional words to avoid important omissions. 4) Introdcution: I'm not happy with the introduction. Although authors say that prostate cancer screening is surrounded by controversies they suggest at the end of the first paragraph (lines 18 to 20) that there is a "survival benefit" for early diagnosed men over those being later diagnosed. The cited paper talks about a decreased risk of metastatic disease. How much a decreased risk of metastatic diseases eventually results in a mortality reduction is shown in the RCT's of the ERSPC and the PLCO. This is between zero and 1 per 1,000 screened men, and zero for overall mortality. Thus, I would be cautious in bringing forward too bold claims about a "survival benefit". Further, in the second paragraph (line 27 to 31) the authors wrongly cited a facts box as a proof of the harms of advanced PC and its treatment. Instead, the facts box shows the harms of prostate cancer screening (overdiagnosis and overtreatment in men with indolent malignancies). 5) Methods: I missed an interrater reliability, which would be common by this kind of qualitative analysis. 6) Discussion: On several occasions authors say that their findings relate to non-cancerous/undiagnosed men. That needs revision (see comment 2). Also, the limitation section is not vey elaborated. I brought up some aspects, which need to be addressed there. 7) Strength and limitation box at the beginning of the paper: I do not understand, why point 3 is a strength of the paper. 
REVIEWER

GENERAL COMMENTS
Thank-you for the interesting and important systematic review and qualitative synthesis. Please see below for some specific comments/suggestions on each section:
Results: the results section could benefit from the following: 1) more clarity between the themes and sub-themes; 2) some discussion of the limitations/strengths of using CASP for quality appraisal (ie why was this tool selected over the others?).
Methods: the methods section could benefit from the addition of the following: 1) include the date that the search was completed; 2) more details around the analysis and how themes were interpreted from the primary studies.
Discussion: The limitations section and concluding remarks could benefit from some more detailed synthesis (e.g., interpretation of the CASP ratings could be worked in/the conclusion is a valuable opportunity to present the main take-aways for how this research can potentially impact the delivery of healthcare).
Also, it would be good to double check the paper for grammatical issues.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 7. Throughout the paper, authors use the words "prevention" and "early diagnosis= early detection" interchangeable. Prevention is not early detection, however. For instance, in the introduction authors discuss PSA screening, what is early detection of a cancer that already exists. Screening does not prevent cancer. Because studies document that a certain number of lay people holds the misconception that screening would prevent cancer, I suggest that within the current study here, authors should be very clear about what they are after. It seems it is "early detection" but the title and certain parts of the paper talk about "prevention." RESPONSE All terms implying prevention have been replaced with 'early detection'.
8. The aim of the study is to determine and evaluate evidence of men who had not been diagnosed with prostate cancer. However, of the 7 populations reviewed 3 populations include men with a prostate cancer diagnosis and in some others there are men with elevated risk (including family history of PC). Whereas in the first setting (there is already a diagnosis) we do not talk about "early diagnosis/early detection" anymore (thus, opposing the aim of the study), the latter-as a high risk population-may also differ in certain ways from low-risk, undiagnosed men. There are different ways of how to treat this aspect: First, the aim of the study needs to be extended to make it clear that all results apply to all men (regardless of state of diagnosis). This would be the easiest but also mingles together findings, which I think might be better separated. Here is why: PSA testing in men with an PC diagnosis (is called testing not early detection anymore in diagnosed men) make a lot of sense because the relative change in the PSA value over time helps predict the potential recurrence of PC. PSA screening/early detection of PC may make sense in men with elevated risk (less controversy than it is on early detection in average-risk men). Further, in both of these groups the threat of prostate cancer is quite real, what should influence preferences and attitudes. This is a very different situation in men without a diagnosis or the knowledge of an elevated risk. Also, and as the authors point out rightly, for average risk men PSA screening/early detection is surrounded by a lot of controversy due to very modest disease-specific mortality benefits (about 1 in 1,000; only shown in the ERSPC trial, in the PLCO no reduction), no overall mortality benefit, and the harms of overdiagnosis/overtreatment (in about 35 in 1,000). Based on this evidence from RCT, early detection of PC had a D recommendation by the US Preventive Task Force, which was changed to a C recommendation after a lot of social/political pressure (not scientific). Due to the fact that testing/early detection might be in some men more appropriate than in others, pulling results together seems a bit awkward to me. The most stringent analysis would therefore be to only report results on average risk men.
RESPONSE
While we have included studies which evaluated perspectives of men with and without prostate cancer, only results for men without prostate cancer are included in this review. A statement to this effect has been added to the analysis section.
9. This suggestion may lead to the argument that there are already so few studies that taking of these with men at elevated risk or with diagnosed men would only leave few. Yet, when going through the literature search algorithm for this study I wondered why there is no inclusion of words such as "PSA" or "early detection" paired with attitudes, preferences, and also with decision making. I suggest running new literature search using these additional words to avoid important omissions.
The search was conducted again with the suggested MeSH terms. Using the Boolean operator 'AND' resulted in 33 papers, none of which fitted our criteria; using 'OR' yielded 49864 papers but added no new eligible paper. We found that the suggested approach, while worth investigating, tended to produce randomised controlled trials and not qualitative research. We seek editorial advice on whether we need to provide this information in our manuscript.
10. Introduction: I'm not happy with the introduction. Although authors say that prostate cancer screening is surrounded by controversies they suggest at the end of the first paragraph (lines 18 to 20) that there is a "survival benefit" for early diagnosed men over those being later diagnosed. The cited paper talks about a decreased risk of metastatic disease. How much a decreased risk of metastatic diseases eventually results in a mortality reduction is shown in the RCT's of the ERSPC and the PLCO. This is between zero and 1 per 1,000 screened men, and zero for overall mortality. Thus, I would be cautious in bringing forward too bold claims about a "survival benefit".
We have cited DallEra (2012) to provide evidence that quality of life is optimised with current techniques of active surveillance. Although we have stated that active surveillance may be beneficial, we have acted on the reviewer's advice and amended our statement about survival benefit.
11. Further, in the second paragraph (line 27 to 31) the authors wrongly cited a facts box as a proof of the harms of advanced PC and its treatment. Instead, the facts box shows the harms of prostate cancer screening (overdiagnosis and overtreatment in men with indolent malignancies)
This sentence has been removed.
12. Methods: I missed an interrater reliability, which would be common by this kind of qualitative analysis
In attempting to understand a phenomenon from someone else's perspective, we are more accustomed to reaching agreement by discussion on the grounds that personal perspectives are not a matter of a yes/no dichotomy. Interrater reliability seems to us to belong to a positivist epistemology rather than a phenomenological one.
13. Discussion: On several occasions, authors say that their findings relate to noncancerous/undiagnosed men. That needs revision (see comment 2).
As in our response to comment 8, our findings relate only to undiagnosed men.
14. The limitation section is not very elaborated. I brought up some aspects, which need to be addressed there.
We have revised this section, although, in responses 8, 9 and 12, we have explained why some of the suggested limitations do not apply.
15. Strength and limitation box at the beginning of the paper: I do not understand, why point 3 is a strength of the paper
We have removed this point.
Reviewer 2 16. Introduction: the second paragraph in which you state "There appears to be consensus" gives an old reference (2005) there has been a lot of controversy about this topic over the last 10 years. Although you haven't used the US in your research the current statement from the US Prevention Services Task Force recommends shared decision-making for screening healthy men 55 to 69 years of age, which supports your statement. It might be helpful to update this section with this reference, or a similar one that is more up to date.
We have updated the citations as suggested.
17. Introduction: paragraph 3 would benefit from the first and second sentences being referenced to support these statements.
We have made the necessary citation to the first sentence (Noone, 2008) . The second sentence would not benefit from references as it points out the paucity of publications in that area.
18. Results: You describe the study participants, is there any additional data you can add here about demographics of the cohorts included? You touch on ethnicity later in regard to the Italian's included in the Australian studies, and on sexuality, but did any of the other studies include, or attempt to include, ethnic minorities or comment on the sociodemographics?
Where details of ethnicity, sexuality, socioeconomic status, education level and marital status are provided, we have added them to column 3 of Table 1 on pages 7 to 10.
19. If the cohorts are fairly homogenous it might be worth a comment on this in the limitations.
Most papers sought to recruit for diverse socioeconomic status but not ethnicity or sexuality. Only one study (reported in two papers) recruited men from a specific ethnic group (Italian-Australians). A comment has been added to Limitations.
Conclusion:
In your final sentence you say that research is required "to inform the continuing improvement in men's health care" but, unless I have missed it, you haven't laid out in the introduction or discussion any evidence about the improvements in men's health care that this refers to
RESPONSE
We have changed the final sentence to include the words "prostate care" to reflect the focus of the paper.
Reviewer 3 21. Results: the results section could benefit from the following: 1) more clarity between the themes and sub-themes
We apologise that our formatting of themes and subthemes seems to have gone rogue, causing this confusion. Headings have been reformatted. We hope that this has resolved the problem.
22. Some discussion of the limitations/strengths of using CASP for quality appraisal (ie why was this tool selected over the others?)
Please see our response to comment 6. We have used a different quality assessment tool (Kmet, Lee, & Cook, 2004) .
23. Methods: the methods section could benefit from the addition of the following: 1) include the date that the search was completed;
The date has been added. We updated the search to June 2018 without finding additional eligible papers.
24. More details around the analysis and how themes were interpreted from the primary studies.
The analysis has been elaborated.
25
. Discussion: The limitations section and concluding remarks could benefit from some more detailed synthesis (e.g., interpretation of the CASP ratings could be worked in
RESPONSE
Results did not vary in accordance with quality evaluation. We have added a statement to this effect.
26. The conclusion is a valuable opportunity to present the main take-aways for how this research can potentially impact the delivery of healthcare).
We suggested the potential impact of our findings on health care in the first paragraph of the discussion. We would appreciate editorial advice on whether we need to repeat them in the conclusion.
27. Also, it would be good to double check the paper for grammatical issues.
The paper has been reviewed for grammatical errors. We would like to be notified of any we have missed. 
VERSION 2 -REVIEW REVIEWER
GENERAL COMMENTS
Abstract/Results: It would help readers if more clarity was added to the ways that the themes are worded (e.g., I think the actual section of "understanding prostate cancer" in the results section, is more about "knowledge around prostate health and cancer"), unless these headings are coming directly from the primary data. It would also help to see the findings summarized in a table or figure format (the quality assessment ratings can be moved to the appendix if more space is required). Also, add the date that the search was conducted.
Introduction: I think some discussion should be held about the use of decision aids with this population (there is a bit of literature around this).
Conclusions: I think more can be added here to reiterate the findings and suggest specific future directions (ie specify what is meant by the following: "more research to expand knowledge and to inform the continuing improvement in prostate care")
VERSION 2 -AUTHOR RESPONSE
Reviewer 3 3. Abstract/Results: It would help readers if more clarity was added to the ways that the themes are worded (e.g., I think the actual section of "understanding prostate cancer" in the results section, is more about "knowledge around prostate health and cancer"), unless these headings are coming directly from the primary data.
Response:
Our aim was to understand men's perspectives; we therefore looked at how they constructed or made sense of prostate cancer rather than to test their knowledge. Further, although some included papers were about men's knowledge, the more important and consistent theme was men's understanding. We would like to retain our label and interpretation. ________________________________________________________________________________ 4. It would also help to see the findings summarized in a table or figure format (the quality assessment ratings can be moved to the appendix if more space is required).
We attempted to tabulate the results as suggested, but found it to be merely a repetition of material in the text. Each theme in the results section is introduced with a short summary. We would appreciate editorial advice on this matter.
_________________________________________________________________________________ _
5. Also, add the date that the search was conducted.
The days have been added to the months and year in Inclusion Criteria. _________________________________________________________________________________ 6. Introduction: I think some discussion should be held about the use of decision aids with this population (there is a bit of literature around this).
The aim of this review is to evaluate evidence of men's perspectives on prostate care and prostate cancer. Decision-aids, although an important aspect of screening and treatment decisions, are beyond the scope of this investigation.
_________________________________________________________________________________ _ 7. Conclusions: I think more can be added here to reiterate the findings and suggest specific future directions (ie specify what is meant by the following: "more research to expand knowledge and to inform the continuing improvement in prostate care") Response:
We have expanded the conclusion to include specific suggestions for research.
VERSION 3 -REVIEW
REVIEWER
Sujane Kandasamy
McMaster University, Canada REVIEW RETURNED 06-Sep-2018
GENERAL COMMENTS
One more limitation that can be mentioned is that your analysis is confined by the individual study author's interpretations. Also add one sentence about how not including non-heterosexual men and rural communities impacts your findings.
VERSION 3 -AUTHOR RESPONSE
Reviewer 3 1. "One more limitation that can be mentioned is that your analysis is confined by the individual study author's interpretations." Response In all reports of research using qualitative methods, authors are required to present sufficient evidence (quotations, for example) to allow readers to assess the validity of their categorisations and interpretations. As is evident in our assessment of quality, authors had to justify their interpretations. Given our very clear description of the quality assessment process, we argue that it would be inappropriate to make the suggested statement.
